Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 445

The DOI matches its Crossref record; 211 of the 211 references it cites were found in a registry or an index.

Artificial intelligence-based multi-omics analysis fuels cancer precision medicine

He, Xiujing, Liu, Xiaowei, Zuo, Fengli, Shi, Hubing, Jing, Jing·2023·Seminars in Cancer Biology

Abstract

With biotechnological advancements, innovative omics technologies are constantly emerging that have enabled researchers to access multi-layer information from the genome, epigenome, transcriptome, proteome, metabolome, and more. A wealth of omics technologies, including bulk and single-cell omics approaches, have empowered to characterize different molecular layers at unprecedented scale and resolution, providing a holistic view of tumor behavior. Multi-omics analysis allows systematic interrogation of various molecular information at each biological layer while posing tricky challenges regarding how to extract valuable insights from the exponentially increasing amount of multi-omics data. Therefore, efficient algorithms are needed to reduce the dimensionality of the data while simultaneously dissecting the mysteries behind the complex biological processes of cancer. Artificial intelligence has demonstrated the ability to analyze complementary multi-modal data streams within the oncology realm. The coincident development of multi-omics technologies and artificial intelligence algorithms has fuelled the development of cancer precision medicine. Here, we present state-of-the-art omics technologies and outline a roadmap of multi-omics integration analysis using an artificial intelligence strategy. The advances made using artificial intelligence-based multi-omics approaches are described, especially concerning early cancer screening, diagnosis, response assessment, and prognosis prediction. Finally, we discuss the challenges faced in multi-omics analysis, with tentative future trends in this field. With the increasing application of artificial intelligence in multi-omics analysis, we anticipate a shifting paradigm in precision medicine becoming driven by artificial intelligence-based multi-omics technology.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.semcancer.2022.12.009

Cites

211 of 211 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 211 references

Research works printed but not linked: 8

  1. Anderson, 2022, Spatial transcriptomics, Cancer Cell, 40, 895, 10.1016/j.ccell.2022.08.021 · doi:10.1016/j.ccell.2022.08.021
  2. Linnarsson, 2016, 17, 1
  3. Kann, 2021, Artificial intelligence for clinical oncology, Cancer Cell, 39, 916, 10.1016/j.ccell.2021.04.002 · DOI · Paper page
  4. Bhinder, 2021, Artificial intelligence in cancer research and precision medicine, Cancer Discov., 11, 900, 10.1158/2159-8290.CD-21-0090 · DOI · Paper page
  5. Ibrahim, 2022, Assessment of mitotic activity in breast cancer: revisited in the digital pathology era, J. Clin. Pathol., 75, 365, 10.1136/jclinpath-2021-207742 · doi:10.1136/jclinpath-2021-207742
  6. Wang, 2020, 172, 59
  7. T. Guo, T. Lin, N. Antulov-Fantulin, In Exploring interpretable lstm neural networks over multi-variable data, in: International Conference on Machine Learning, PMLR, 2019, pp 2494–2504.
  8. Chaudhary, 2018, Deep learning-based multi-omics integration robustly predicts survival in liver cancer, Clin. Cancer Res.: Off. J. Am. Assoc. Cancer Res., 24, 1248, 10.1158/1078-0432.CCR-17-0853 · DOI · Paper page

Cited by

See all 445

Metadata

Authors
He, X., Liu, X., Zuo, F., Shi, H., & Jing, J.
Venue
Seminars in Cancer Biology
Publisher
Elsevier BV
Published
2023-01
Volume
88
Pages
187-200
ISSN
1044-579X (ISSN-L)
OpenAlex
W4313346475
Cited by
445
References
211
FWCI
21.13
Type
journal article
Language
en
Open access
closed
Funders
  • West China Hospital, Sichuan University
  • National Natural Science Foundation of China (22105137, 81902792, 82172634)
  • Sichuan University (ZYYC20013)
  • Shaoxing Bureau of Science and Technology (2021YFSY0007)
  • National Key Research and Development Program of China (2022YFC2504700, 2022YFC2504703)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Artificial intelligence-based multi-omics analysis fuels cancer precision medicine. https://app.cochat.ai/papers/10.1016/j.semcancer.2022.12.009
The paper
He, X., Liu, X., Zuo, F., Shi, H., & Jing, J. (2023). Artificial intelligence-based multi-omics analysis fuels cancer precision medicine. Seminars in Cancer Biology. https://doi.org/10.1016/j.semcancer.2022.12.009

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.